Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News Lilly begins real-world Covid-19 study of bamlanivimab in New Mexico to assess outcomes in high-risk patients Eli Lilly begins a real-world Covid-19 study of bamlanivimab in New Mexico. Find out how mobile clinics aim to reduce hospitalizations in high-risk patients. bypharmanewsdailyDecember 19, 2020